These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7225501)

  • 1. Increase in blood silicon concentration in patients with renal failure.
    Mauras Y; Riberi P; Cartier F; Allain P
    Biomedicine; 1980 Nov; 33(7):228-30. PubMed ID: 7225501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicon metabolism: the basic facts in renal failure.
    Berlyne G; Dudek E; Adler AJ; Rubin JE; Seidman M
    Kidney Int Suppl; 1985 Dec; 17():S175-7. PubMed ID: 3867790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot study of aluminum plasma level in healthy subjects in Poland].
    Bartoń HJ; Zachwieja Z; Fołta M; Janusz-Grzybowska E; Stompór T; Sułowicz W; Brzezicka M
    Przegl Lek; 2003; 60 Suppl 6():111-4. PubMed ID: 15106472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C measurement and its practical use in patients with various renal diseases.
    Tian S; Kusano E; Ohara T; Tabei K; Itoh Y; Kawai T; Asano Y
    Clin Nephrol; 1997 Aug; 48(2):104-8. PubMed ID: 9285147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid peroxidation, trace elements and anti-oxidant enzymes in chronic renal disease patients.
    Ongajooth L; Ongajyooth S; Likidlilid A; Chantachum Y; Shayakul C; Nilwarangkur S
    J Med Assoc Thai; 1996 Dec; 79(12):791-800. PubMed ID: 9071084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silicon-related syndrome in dialysis patients.
    Saldanha LF; Gonick HC; Rodriguez HJ; Marmelzat JA; Repique EV; Marcus CL
    Nephron; 1997; 77(1):48-56. PubMed ID: 9380238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate.
    Tryba M; Kurz-Müller K; Donner B
    Crit Care Med; 1994 Nov; 22(11):1769-73. PubMed ID: 7956280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
    Gafter U; Mamet R; Korzets A; Malachi T; Schoenfeld N
    Nephrol Dial Transplant; 1996 Sep; 11(9):1787-91. PubMed ID: 8918623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of serum creatinine: recommendations for management and referral.
    Mendelssohn DC; Barrett BJ; Brownscombe LM; Ethier J; Greenberg DE; Kanani SD; Levin A; Toffelmire EB
    CMAJ; 1999 Aug; 161(4):413-7. PubMed ID: 10478168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 and nitric oxide in patients on chronic hemodialysis.
    Tomić M; Galesić K; Markota I
    Ren Fail; 2008; 30(9):836-42. PubMed ID: 18925520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study.
    Devbhandari MP; Duncan AJ; Grayson AD; Fabri BM; Keenan DJ; Bridgewater B; Jones MT; Au J;
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):964-70. PubMed ID: 16675230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.